426 



SUBJECT INDEX 



Tobacco mosaic virus, 112, 127, 200 



Transformation 



Berry-Dedrick, fibroma-myxoma and, 



276, 302-305 

 Boerlage fibroma virus and, 304 

 Shope fibroma virus, myxoma virus and, 

 302-305 



Transforming agent, myxoma virus and, 

 304 



Trypsin 



Chu inhibitor and, 36 

 influenza virus, soluble antigen and, 128 

 myxovirus hemagglutination and, 26, 85 

 receptor-destroying enzyme and, 32, 58 



Tumor viruses, 65, see also individual virus 



Uganda S encephalitis virus, hemag- 

 glutination and, 42 



Ultraviolet irradiation, 288 



myxovirus hemagglutination and, 26, 31 



Urea, myxovirus hemagglutination and, 27 



Urine mucoprotein, see also Mucoprotein 

 prosthetic groups of, 56 

 receptor-destroying enzyme and, 56 



Vantigen, see Antigen 



V 2 carcinoma, rabbit papilloma virus and, 

 333 



Vaccines, bacterial, host protection and, 159 

 yellow fever virus, attenuation and, 226 



Vaccinia virus, 2, 51, 103, 113, 124, 183, 

 201, 221, 320 

 Bacillus megatherium and, 13-14 

 benzimidazole and, 215 

 deoxyribonucleic acid and, 4, 8 

 dermotropic vaccinia virus, interference 



between, 167 

 2, 6-diaminopurine and, 21 8 

 electron microscopy and, 77-78 

 elementary bodies and, 76, 77 

 fibroblast roller tube cultures and, 234 

 fluorescent antibody staining and, 78 

 foot-and-mouth disease virus, inter- 

 ference between, 164 

 fowlpox virus, interference between, 164 

 genetic recombination and, 229-230 

 growth of, 137-138 

 hemagglutination and, 44-45 

 human epidermoid carcinoma and, 78 

 identification of, 76 



inactivated vaccinia virus, interference 



between, 171 

 infection spread, hyaluronidase and, 235 

 influenza virus, interference between, 



162 

 intracellular soluble antigens and, 132 

 lag period 



"enhancement effect" and, 117 

 recoverable infective virus and, 116, 

 117-118, 125, 126 

 DL-methoxinine and, 206, 217 

 mouse mammary carcinoma virus, inter- 

 ference between, 164 

 psittacosis virus and, 4, 8 

 rabbit corneal cells and, 76 

 recombination and, 299-301 

 release of, 141, 142 

 0-2-Thienylalanine and, 217 

 Vanessa cardui, nuclear polyhedral virus 



and, 388 

 Vanessa io, nuclear polyhedral virus and, 



388 

 Variation, see Virulence variation 

 Varicella virus 



release of, 141, 142 

 tissue culture and, 235 

 Variola vaccinia virus, 4 

 Venezuelan equine encephalitis virus 

 hemagglutination and, 42 

 yellow fever virus, interference between, 

 163 

 Vesicular stomatitis virus 



autointerference and, 168, 181 

 equine encephalomyelitis virus, inter- 

 ference between, 163 

 heterotypic vesicular stomatitis virus, 



interference between, 164, 181 

 incomplete virus and, 151 

 infection spread, hyaluronidase and, 235 

 Newcastle disease virus, interference 



between, 162, 182 

 serological types 

 cattle and, 7 

 swine and, 7 

 Vibrio cholerae, receptor-destroying en- 

 zyme of, 29, 30, 32-33, 41, 52, 53, 55, 58, 

 121, 122, 123, 124, 125, 128, 135, 140, 

 201, 214 

 Victorian strain, Newcastle disease virus, 

 hemagglutination and, 28 



